Danong, Bradley .

HRN: 22-11-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2022
CEFUROXIME 750MG (VIAL)
10/27/2022
11/03/2022
IVTT
320mg
Q8
Pcap
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes